Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06487247

HEME Home Transfusion Program

Led by Dana-Farber Cancer Institute · Updated on 2025-09-17

700

Participants Needed

2

Research Sites

194 weeks

Total Duration

On this page

Sponsors

D

Dana-Farber Cancer Institute

Lead Sponsor

N

National Cancer Institute (NCI)

Collaborating Sponsor

AI-Summary

What this Trial Is About

This research study is evaluating whether a new care delivery program that provides access to home blood transfusions in hospice (i.e, HEME-Hospice) compared to regular standard of care improves quality of life, mood, and end-of-life health care utilization for patients with hematologic malignancies.

CONDITIONS

Official Title

HEME Home Transfusion Program

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of relapsed or refractory hematologic malignancy
  • Age 18 years or older
  • Receiving primary oncologic care at Dana-Farber Cancer Institute with at least 2 outpatient visits in the past 12 months
  • Received at least one red blood cell or platelet transfusion since blood cancer diagnosis without severe transfusion reaction
  • Resides within the Care Dimensions Hospice service area
  • Physician-estimated prognosis of six months or less
  • Identified informal caregiver aged 18 years or older (for caregiver participants)
Not Eligible

You will not qualify if you...

  • Age younger than 18 years
  • Already enrolled in hospice care
  • Lives in a nursing home or assisted living facility
  • History of serious adverse transfusion reaction
  • Caregiver younger than 18 years

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Brigham and Women's Hospital

Boston, Massachusetts, United States, 02215

Actively Recruiting

2

Dana-Farber Cancer Institute

Boston, Massachusetts, United States, 02215

Actively Recruiting

Loading map...

Research Team

O

Oreofe Odejide, MD, MPH

CONTACT

S

Sunny Rosenthal, MPH

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

HEME Home Transfusion Program | DecenTrialz